Emergency Department Probiotic Treatment of Pediatric Gastroenteritis
Status:
Completed
Trial end date:
2017-05-01
Target enrollment:
Participant gender:
Summary
The objective of this study is to determine for previously healthy children who present to a
Canadian Emergency Department (ED) with acute gastroenteritis (infection or irritation of the
digestive tract); if compared with placebo, the administration of a probiotic agent
(Lacidofil) will result in a significantly lower proportion of children developing moderate
to severe disease over the subsequent 2 weeks and will not be associated with a significantly
greater occurrence of side effects.
Phase:
Phase 3
Details
Lead Sponsor:
Dr. Stephen Freedman Sarah Williamson-Urquhart
Collaborators:
Alberta Children's Hospital Canadian Institutes of Health Research (CIHR) Children's Hospital of Eastern Ontario Institut Rosell Lallemand IWK Health Centre London Health Sciences Center, Children's Hospital St. Justine's Hospital The Hospital for Sick Children